ideas

Price Action Impressive Volume Not So Much

Capitalist Bull: Price Action Impressive Volume Not So Much

PagesHome
Leading Growth Stocks Analysis
Short Trading Ideas
SERVICES
Newsletter Sign Up
Interviews
About Us
Disclaimer
Price Action Impressive Volume Not So MuchMarket price action has been impressive by any respect. Despite persistent bad news from around the world, and numerous internal red flags, the NYSE advance decline line continues to trade near new highs, and the market marches higher […]

The Struggles Of Gilead Sciences

View gallery.After last week’s hammering of biotech stocks, many have not been able to recover to hit new highs with the overall market.Previous high flyers such as Agios Pharmaceuticals Inc (NASDAQ: AGIO) and Receptos Inc (NASDAQ: RCPT) have bounced, but still lag the Nasdaq.Others, such as Bluebird Bio Inc (NASDAQ: BLUE) have actually managed to eek out new highs.Unfortunately, there are the […]

Could This Biotech Stock Fall Even Further?

View gallery.Sometimes the stock market gets on a run and traders enjoy the ride.The same can apply with individual stocks. Once the wind is at their backs, traders can take off and run to previously unforeseen heights.However, all runs must come to an end eventually. The million-dollar question is, when?This is where technical analysis can sometimes help.Commonly, stocks getting ready […]

Here's The Latest Biotech Breakout

View gallery.Until the markets pullback a bit, investors and traders will ride this gravy train as long as it goes. Thanks to the market run-up a lot of stocks already seem somewhat extended. However, there are some stocks that are a little late to the party and are just now breaking higher.For example, Celldex Therapeutics, Inc. (NASDAQ: CLDX) just recently broke […]

2 Skyrocketing Biotech Stocks In A Stalling Market

View gallery.Last week’s market price action was somewhat like watching paint peel. In other words, there just wasn’t much going on.Even though the market edged higher for the fourth straight week and the S&P 500 hit new record highs, the gains came during the smallest market moves since 1979.After Monday, the benchmark S&P rose or fell less than 0.1 percent […]

Not Your Average Millionaire: The Hit and Miss Career of James Altucher

The career of media mogul James Altucher could be likened to a 20-year roller coaster ride, or a sprint through a minefield. Few have experienced a career as erratic, and with as many highs and lows as that of Altucher. Despite his many setbacks, he has been a pace setter in the fields of finance, corporate ownership, management, writing, blogging […]

How Adam Feuerstein Follows The Biotech Sector

View photo.Anyone who trades or invests in biotech stocks knows how volatile they can be, according to Adam Feuerstein.Feuerstein is a senior columnist for TheStreet.com, and he recently joined Benzinga’s #PreMarket Prep to talk about how he keeps track of what’s going on in the biotech sector.“I think the most important thing for investors in the biotech sector is just […]

Update: Intel To Apply Big Data Into Medicine – Intel Corporation …

SummaryIntel is planning to apply Big Data into medicine by pairing smartwatches with its analytics software.
Intel and the Michael J. Fox Foundation have joined hands for conducting a study on Parkinson’s disease.
In our original article, we said that Intel has tremendous opportunities in the IoT, although we didn’t anticipate that Intel would go into medicine.
The recent news confirms our view […]

TraderFeed: The Golden Age of Trading and Investment–And Its …

Tadas Viskanta, in 2012, made the argument that we are living in a golden age for individual investors because of the availability of data, the increased access to markets, and the ability to trade multiple asset classes and strategies via ETFs. As Tadas observes more recently, costs have come down significantly for individual traders and new ETF products place individual […]

Trade Decline Of Golf Through These 2 Stocks – Callaway Golf …

SummaryGolf participation has been in decline since 2003.
Main causes are generational preferences and falling real incomes.
Ways to trade this trend are shorting Callaway and Clubcorp.
Golf is in trouble in the United States. The main reasons for this is the lack of adoption of the sport amongst the 18-30 demographic due to falling youth income and an increasing lack of patience […]